Market News How it works Learn FAQ
| GPUS 0.1689 34.05% | SHFS 0.1324 -61.39% | XXII 0.1977 -8.34% | NVD 4.19 0.96% | LUCD 0.411 25.42% | SPCX 147.49 1.89% | T 20.93 -7.96% | SOXL 83.56 1.77% | NU 15.16 2.92% | NOK 8.14 3.30% | EWZ 42.59 1.77% | NVDA 210.96 -0.59% | RIME 0.106 -12.90% | INTC 86.96 1.72% | TSLG 4.87 -1.62% | AAL 12.11 -3.89% | BBD 4.07 3.04% | STLA 4.06 -4.81% | SOXS 52.46 -1.85% | RWM 14.55 0.34% | HYG 77.05 -0.06% | MYND 0.24 47.42% | RBNE 0.19 -2.56% | YFOR 0.2236 -1.58% | BITO 10.83 -0.28% | SPDN 8.54 0.47% | TQQQ 66.29 -0.20% | TSLL 9.76 -1.21% | VZ 44.66 -1.19% | SPTI 27.63 -0.11% | YMAT 2.05 6.77% | CRWV 54.235 -2.46% | INFY 12.35 -6.58% | RIG 6.41 5.43% | F 11.6 -2.85% | GRAB 2.79 -2.11% | AIOK 12.02 182.82% | SQQQ 39.68 0.20% | ONDS 6.2 2.99% | LABT 0.31 -36.67% | AAPL 347.725 -0.14% | CDE 13.45 -3.10% | PCG 12.63 -2.70% | IREN 24.905 -2.37% | SOFI 14.615 -1.05% | XLE 69.33 2.60% | NFLX 65.85 -1.79% | QID 14.55 0.14% | CLRO 3.25 69.27% | WULF 11.32 0.00%
SNSenti Biosciences, Inc. logo

Senti Biosciences, Inc. (SNTI)

NASDAQ Global Market · Currency in USD
$0.19 ▼ 0.00 (-1.10%)
At close: Oct 23, 4:00 PM ET. Market closed.
$0.20 ▲ +0.01 (+5.15%)
After hours: Oct 23, 7:40 PM ET

Summary

Previous Close
$0.19
Open
$0.17
Day's Range
$0.17 – $0.19
52 Week Range
$0.17 – $2.88
Volume
366,392
Avg. Volume
711,413
Market Cap
$5.87M
Beta (5Y Monthly)
2.22
PE Ratio (TTM)
--
EPS (TTM)
-$1.59
Earnings Date
Nov 12, 2026
Forward Dividend & Yield
--
Ex-Dividend Date
--
1y Target Est
$6.00

Profile: Senti Biosciences, Inc.

Sector
Healthcare
Industry
Biotechnology
Full-time employees
39
CEO
Timothy K. Lu

Senti Biosciences, Inc. is a pioneering company specializing in gene circuit technology. They focus on creating advanced cell and gene therapies that incorporate sophisticated gene circuits, essentially biological computers, to genetically reprogram cells. This allows the modified cells to interpret biological cues, make precise decisions, and react appropriately within their specific cellular surroundings.

Earnings

Next report: Thu, Nov 12, 2026
EPS estimate -$0.21 · Revenue est. $15.87K
DateEst.Actual
Aug 14, 2026-$0.27-$0.41Miss
May 14, 2026-$0.27-$0.14Beat
Mar 27, 2026-$0.43-$0.53Miss
Nov 13, 2025-$0.59-$0.69Miss
Aug 7, 2025-$0.90-$0.56Beat
May 6, 2025-$0.58-$1.41Miss

Analyst view

Consensus price target
$6.00 ▲ +3,084.7%
Range $6.00 – $6.00
Rating: Buy
Buy 50% · Hold 50% · Sell 0%

Get free alerts on SNTI and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.